Literature DB >> 29432704

Clinicopathological features and comorbidities of cats with mild, moderate or severe hyperthyroidism: a radioiodine referral population.

Natalie Watson1, Jane K Murray1,2, Sonja Fonfara3, Angie Hibbert4.   

Abstract

OBJECTIVES: This study sought to explore the clinicopathological features and comorbidities of cats with mild, moderate and severe hyperthyroidism in a radioiodine referral population.
METHODS: Medical records were reviewed, along with results of serum biochemistry, urinalysis, systolic blood pressure and diagnostic imaging performed at the time of radioiodine referral. Cats were grouped by total thyroxine (TT4) levels as mildly (TT4 60.1-124.9 nmol/l), moderately (TT4 125-250 nmol/l) or severely (TT4 >250 nmol/l) hyperthyroid at the time of diagnosis and referral.
RESULTS: Thirty percent (42/140) of the cats were <10 years old at diagnosis. In 24.3% (34/140), hyperthyroidism was diagnosed incidentally. The time between diagnosis and referral for radioiodine was significantly longer in cats with severe hyperthyroidism at the time of referral ( P = 0.004). An increase in severity group between the time of diagnosis and referral occurred in 38.6% (54/140) of cats. At referral, 54.3% (25/46) of cats with mild, 66.7% (42/63) with moderate and 80.6% (25/31) with severe hyperthyroidism were unstable despite ongoing medical or dietary management. The prevalence of cardiac abnormalities was significantly increased in cats with severe hyperthyroidism ( P = 0.014) compared with those with mild or moderate hyperthyroidism. There was no significant difference in the likelihood of renal disease ( P = 0.708) or hypertension ( P = 0.328) between the groups. CONCLUSIONS AND RELEVANCE: Incidental diagnosis of hyperthyroidism occurs commonly, potentially owing to increased disease screening. Cats with severe hyperthyroidism at referral were more likely to be chronically hyperthyroid with a history of poor stabilisation. This subset of patients was significantly more likely to have cardiac abnormalities. Thyrotoxic cardiomyopathy may ultimately affect patient suitability for curative treatments (radioiodine or thyroidectomy) owing to higher anaesthetic risks and potential for decompensation into congestive heart failure with the stress of travel and hospitalisation. Curative therapy should be considered before the development of severe hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29432704     DOI: 10.1177/1098612X18755925

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  4 in total

1.  Randomised clinical trial evaluating the effect of a single preappointment dose of gabapentin on signs of stress in hyperthyroid cats.

Authors:  Matthew Gurney; Lou Gower
Journal:  J Feline Med Surg       Date:  2022-04-28       Impact factor: 1.971

2.  'The Mercury Challenge': feline systolic blood pressure in primary care practice - a European survey.

Authors:  Andrew Sparkes; Catherine Garelli-Paar; Thomas Blondel; Emilie Guillot
Journal:  J Feline Med Surg       Date:  2022-06-27       Impact factor: 1.971

3.  ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats.

Authors:  Virginia Luis Fuentes; Jonathan Abbott; Valérie Chetboul; Etienne Côté; Philip R Fox; Jens Häggström; Mark D Kittleson; Karsten Schober; Joshua A Stern
Journal:  J Vet Intern Med       Date:  2020-04-03       Impact factor: 3.333

Review 4.  Updates on Laboratory Evaluation of Feline Cardiac Diseases.

Authors:  Alessandra Gavazza; Andrea Marchegiani; Lorenza Guerriero; Vanessa Turinelli; Andrea Spaterna; Sara Mangiaterra; Livio Galosi; Giacomo Rossi; Matteo Cerquetella
Journal:  Vet Sci       Date:  2021-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.